Newspaper icon
The latest issue of Financial Standard now available as an e-newspaper
READ NOW

Search Results

Showing 101 - 110 of 120 results for "Biotech"

Biotech bouncing back

HAMISH MADDEN  |  WEDNESDAY, 17 JAN 2007
The Australian biotech sector finished 2006 in a healthy position with stronger valuations buoyed by the interest of overseas investors while 2007 looks set to continue the trend on the back of significant news flow and trial results for a range of ...

Smallco scores four stars from S&P

HAMISH MADDEN  |  MONDAY, 27 NOV 2006
The Smallco Investment Fund has received a four star rating from Standard & Poor's Fund Services in recognition of its solid underlying performance to date. S&P said the ratings reflects S&P's belief that Smallco's investment returns will consistently ...

There will be mistakes: eG Capital

HAMISH MADDEN  |  THURSDAY, 12 OCT 2006
... that mistakes in the sector are inevitable and choosing the right investment manager is crucial. Director of specialist biotech investment manager eG Capital, Brad Ross-Sampson, believes the biotech sector in Australia is still immature but growing fast ...

Private equity capital raising breaks $4bn for 2005-06

ALEX DUNNIN  |  THURSDAY, 5 OCT 2006
... In contrast, industrial and energy sectors accounted for 9 per cent, the medical and health accounted for 8 per cent, biotech accounted for 6 per cent and media and communications accounted for 3 per cent. Other investments including agribusiness, business ...

QIC and eG Capital form strategic alliance

ALEX DUNNIN  |  TUESDAY, 26 SEP 2006
QIC, through its Queensland Biotechnology Fund (QBF), has taken a 20 per cent position in the biotech specialist investment house eG Capital. eG Capital, otherwise known as Emerging Growth Capital Pty Ltd, is a full service financial advisory and brokerage ...

Biotech looms as boom sector

ALEX DUNNIN  |  MONDAY, 14 AUG 2006
The biotech sector is emerging as a sunrise opportunity for investors who have an eye on the long term, looking for very strong capital gains. "Biotech is all about the use of biological processes to create commercial products," said Brad Ross-Sampson ...

MTAA Super invests in biotech JV

The Motor Trades Association of Australia Superannuation Fund (MTAA Super) announced that it has entered into a joint venture with Bio Innovation SA, a world class research and development entity and facility. The new $35 million joint venture will ...

M&A activity slows down: KPMG

... of super funds, a further increase in activity by private equity firms and further rationalisation in the transport and biotech sectors.

Market Wrap

AAP  |  MONDAY, 10 OCT 2005
... weeks for the year slightly higher after data showing smaller-than-expected job losses in September and gains in shares of biotech companies developing avian flu treatments. Heavy equipment maker Caterpillar rose in response to investors' perceptions ...

Melbourne Biotech group wins Chinese investor

Melbourne's reputation as a biotech investment hub continues to grow with the recent awarding of a $3 million investment from a Chinese company to Melbourne based herbal medicine and therapeutic science group R&D. The agreement is between RMIT University's ...